share_log

ネクセラ---大幅続伸、アッヴィ社との創薬提携においてマイルストンを受領

Nexela---significantly extended, received milestones in drug discovery collaboration with AbbVie.

Fisco Japan ·  Jun 26 22:20


Nexella (4565) continues to surge. It has announced the achievement of an important milestone in the research stage of the drug discovery partnership with Abbvie, targeting multiple targets in neurological diseases. As a result, they will receive 10 million dollars, most of which will be recognized as revenue in 2024, and the rest in 2025 and beyond. With the achievement of the first milestone in the drug discovery partnership, further progress in the project is expected in the future.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment